Coverage
		- 
			May 04, 2015
			
			DaVita Inc. said Monday it set aside $495 million as part of a tentative deal to resolve a False Claims Act whistleblower suit for allegedly bilking taxpayers for reimbursement of intentionally overused dialysis drugs, which a plaintiff's attorney called the largest settlement for an FCA case brought without government intervention. 
10 other articles on this case. 
View all »